Clinical Trials Browser

INDUSTRY × radium Ra 223 dichloride × 1 year × Clear all

NCT07611110 2026-05-28

VECTRA-01

Phase 3 Recruiting

Prostatic Neoplasms

NCT04597125 2026-05-11

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

Phase 4 Active not recruiting

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT00699751 2026-02-23

ALSYMPCA

Phase 3 Completed

921 enrolled 43 charts

Hormone Refractory Prostate Cancer

NCT02141438 2025-10-16

REASSURE

1,472 enrolled 18 charts

Metastatic Castration-resistant Prostate Cancer

NCT04521361 2025-09-19

A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones

Phase 1 Completed

Bone Metastatic Castration-resistant Prostate Cancer

NCT02803437 2025-07-10

Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

Prostatic Neoplasms, Castration-Resistant